Hormone | Effect on metabolism | Example affected conditions | Author |
---|---|---|---|
Estrogen | Increases total cholesterol, triglycerides, and high-density lipoproteins, decreases low-density lipoproteins | Cholesterol biosynthesis disorders, Cholesterol storage disorders, GSD | |
 | Increases circulating glucose and insulin | FAOD, GSD, disorders with risk of hypoglycemia | |
 | Decreases muscle glucose uptake via repression of GLUT4 expression | Muscle-predominant GSD | Barros et al. [52] |
 | Decreased absorption of B vitamins, specifically riboflavin, thiamine, and pyridoxine | PDH deficiency, Homocystinuria | |
 | Increased risk of venous thromboembolism | Homocystinuria, Cobalaminopathies | Den Heijer et al. [23] |
Progestins | Increase triglycerides and high-density lipoproteins, decreases low-density lipoprotein | Cholesterol biosynthesis disorders, Cholesterol storage disorders, GSD | |
 | Decrease bone mineral density with DMPA | Disorders with risk for poor bone health | ACOG [4] |
Combined estrogen and progestin | Changes in plasma amino acid profiles: decreases glutamine, glycine, proline, lysine, hydroxyproline, ornithine, tyrosine and increases isoleucine and phenylalanine | PKU, IVA, GAMT deficiency, Lysinuric Protein Intolerance | |
 | Increase total cholesterol, triglycerides, and high-density lipoproteins | Cholesterol biosynthesis disorders, Cholesterol storage disorders, GSD | Wang et al. [57] |
 | Decrease free and total carnitine | Carnitine Uptake deficiency, Secondary carnitine deficiency | Bach et al. [58] |
 | Increase cholic acid | Disorders of bile acid metabolism | Connolly et al. [44] |
 | Decrease chenodeoxycholic acid | Cerebrotendinous Xanthomatosis | Connolly et al. [44] |
 | Increase ceruloplasmin | Wilson disease | Roberts et al. [59] |